$ACT Headlines Actavis reportedly in talks to buy Salix

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$ACT Headlines

Actavis reportedly in talks to buy Salix Pharma 11:51 a.m. Sept. 24, 2014 - Russ Britt
Actavis's Salix play undermines Allergan defense 11:43 a.m. Sept. 24, 2014 - Russ Britt
Actavis reportedly in talks to buy Salix Pharma 11:42 a.m. Sept. 24, 2014 - Russ Britt
Actavis shares rise on report of Pfizer approach 2:49 p.m. Sept. 23, 2014 - Ciara Linnane
Botox maker Allergan rejected Actavis takeover bid 6:18 p.m. Sept. 22, 2014 - Jonathan D. Rockoff
In focus: Market giving mixed signals 7:03 p.m. Sept. 17, 2014 - Lawrence G. McMillan
DEA restricts narcotic pain-drug prescriptions 7:27 p.m. Aug. 21, 2014 - Louise Radnofsky
Actavis raises guidance as earnings top views 8:11 a.m. Aug. 5, 2014 - MarketWatch.com
Nasdaq needs to turn up the volume 11:59 a.m. July 17, 2014 - The Trading Deck
Leon Cooperman talks up Citi, Thermo Fisher 11:20 a.m. July 16, 2014 - Sue Chang
Leon Cooperman likes Thermo Fisher, Citi, Actavis 11:06 a.m. July 16, 2014 - Sue Chang
10 biggest S&P 500 winners and losers for 2014 10:44 a.m. July 1, 2014 - Philip van Doorn
Affiliated Managers Group to join S&P 500 5:33 p.m. June 24, 2014 - Wallace Witkowski
10 best-performing S&P 500 stocks of 2014 2:38 p.m. June 2, 2014 - Philip van Doorn
Pfizer's plan to relocate after merger deal draws lawmakers' fire 11:30 a.m. May 9, 2014 - Russ Britt
Corner drug store may move overseas to save on taxes 6:31 a.m. April 16, 2014 - Al Lewis
Intuitive Surgical slumps; Facebook extends rally 3:41 p.m. April 9, 2014 - Sue Chang
Actavis acquires Silom Medical for $100 million 10:19 a.m. April 1, 2014 - MarketWatch.com
The 10 most overbought stocks in the S&P 500 index 12:19 p.m. March 25, 2014 - The Trading Deck
UK drug rejection, patent concerns take a bite out of Celgene shares 1:33 p.m. March 14, 2014 - Russ Britt


Trade-Ideas: Actavis (ACT) Is Today's New Lifetime High Stock 9:47 a.m. Sept. 25, 2014 - TheStreet.com
Dow Index Overseers Make It Official: U.S. Firms Only 8:43 p.m. Sept. 24, 2014 - The Wall Street Journal Interactive Edition
Facebook, Three Other Leaders In Striking Distance 5:08 p.m. Sept. 24, 2014 - Investors Business Daily
Allergan and Salix Pharmaceuticals Up on Takeover Rumors - Analyst Blog 4:45 p.m. Sept. 24, 2014 - Zacks.com
Valeant Ends Prince Charming Act; Allergan Hopes Rise 3:11 p.m. Sept. 24, 2014 - Investors Business Daily
P&G Exits Pet Care; To Vend Europe Unit to Spectrum Brands - Analyst Blog 2:00 p.m. Sept. 24, 2014 - Zacks.com
Ackman Threatens to Sue Allergan 5:30 p.m. Sept. 23, 2014 - The Wall Street Journal Interactive Edition
Inversions Thwarted, But Real Tax Fix Needs Congress 5:28 p.m. Sept. 23, 2014 - Investors Business Daily
Why Actavis (ACT) Stock Is Higher Today 2:36 p.m. Sept. 23, 2014 - TheStreet.com
Bloomberg: Pfizer approached Actavis about merger 2:27 p.m. Sept. 23, 2014 - Seeking Alpha
Actavis (ACT) Marked As A Barbarian At The Gate 2:25 p.m. Sept. 23, 2014 - TheStreet.com
Hottest Healthcare Stocks Now – TEVA ACT PODD CELG 1:45 p.m. Sept. 23, 2014 - InvestorPlace.com
Allergan-Ackman Flame War Reignites On Salix Rumors 10:47 a.m. Sept. 23, 2014 - Investors Business Daily
Wall Street Breakfast: Treasury Tightens Rules To Fight Tax Inversions 6:32 a.m. Sept. 23, 2014 - Seeking Alpha
Allergan Rejected Offer From Actavis 6:48 p.m. Sept. 22, 2014 - The Wall Street Journal Interactive Edition
WSJ: Allergan closing in on Salix deal after turning down Actavis 6:27 p.m. Sept. 22, 2014 - Seeking Alpha
Why Actavis (ACT) Stock Is Down Today 3:22 p.m. Sept. 22, 2014 - TheStreet.com
Why Actavis (ACT) Stock Is Down Today 3:22 p.m. Sept. 22, 2014 - TheStreet.com
Actavis Enters New Markets To Boost Profits, Sales 5:08 p.m. Sept. 19, 2014 - Investors Business Daily
Hottest Healthcare Stocks Now – PTCT BLUE ACT HCA 1:45 p.m. Sept. 19, 2014 - InvestorPlace.com


Actavis Confirms Generic Butrans® Patent Challenge 4:05 p.m. Sept. 25, 2014 - PR Newswire - PRF
Critical Alerts For Tekmira Pharmaceuticals, Herbalife, Alcoa, Actavis and Twitter Released By InvestorsObserver 10:37 a.m. Sept. 24, 2014 - PR Newswire - PRF
Critical Alerts For Tekmira Pharmaceuticals, Herbalife, Alcoa, Actavis and Twitter Released By InvestorsObserver 9:39 a.m. Sept. 24, 2014 - PR Newswire - PRF
Twenty Employers to Attend Annual Life Science Hiring Event Next Week 9:00 a.m. Sept. 22, 2014 - PR Newswire - PRF
Study Data Release, Dividends and Shares Repurchases, Committee Recommendations, New Partners, and Upcoming Conferences - Research Reports on Celgene, Abbott, Actavis, UnitedHealth and Bristol-Myers 9:00 a.m. Sept. 16, 2014 - PR Newswire - PRF
FDA Advisory Committee Recommends Against Approval of Actavis' Nebivolol/Valsartan Fixed-Dose Combination NDA for Treatment of Hypertension 5:10 p.m. Sept. 9, 2014 - PR Newswire - PRF
Equity Coverage on Pharma Industry - Zoetis, Actavis, Horizon Pharma, Hospira, and Endocyte 8:55 a.m. Sept. 9, 2014 - PR Newswire - PRF
Actavis Announces FDA Acceptance of the NDA Filing for Ceftazidime-Avibactam, a Qualified Infectious Disease Product 8:00 a.m. Sept. 5, 2014 - PR Newswire - PRF
Actavis Announces FDA Acceptance for Filing of NDA for Eluxadoline 9:20 a.m. Sept. 2, 2014 - PR Newswire - PRF
Upcoming Conferences Schedule, Clinical Trial Data Release Schedule, Milestone Payment, and Expansion of Partnership - Research Reports on Celgene, Actavis, Regeneron, ISIS and UnitedHealth 9:10 a.m. Aug. 29, 2014 - PR Newswire - PRF
Actavis to Present at Morgan Stanley Global Healthcare Conference 2014 4:05 p.m. Aug. 26, 2014 - PR Newswire - PRF
Acquisitions, Clinical Study Results, Dividends, and Technical Updates - Research Reports on Mallinckrodt, Celgene, Actavis, UnitedHealth and Bristol-Myers 8:50 a.m. Aug. 21, 2014 - PR Newswire - PRF
Depomed Prevails in Gralise® ANDA Litigation Blocking Generic Entry Until 2024 11:15 a.m. Aug. 19, 2014 - PR Newswire - PRF
Actavis Announces Positive Topline Results From The Phase III Program Of Ceftazidime-Avibactam In Patients With Complicated Intra-Abdominal Infections(cIAI) 7:24 a.m. Aug. 19, 2014 - PR Newswire - PRF
Collaborations, Financial Results, and Technical Updates - Research Reports on Actavis, UnitedHealth, Bristol-Myers Squibb, Celgene and Aetna 8:40 a.m. Aug. 12, 2014 - PR Newswire - PRF
Actavis Net Revenue Increases 34% to $2.67 Billion in Second Quarter 2014; Non-GAAP EPS Increases 70% to $3.42 7:00 a.m. Aug. 5, 2014 - PR Newswire - PRF
Earnings Releases, Technical Updates, FDA Acceptances, and New Products - Research Reports on Newfield Exploration, YPF, HCA, Actavis and 3M 8:50 a.m. Aug. 4, 2014 - PR Newswire - PRF
Medicines360 and Actavis Announce FDA Acceptance for Filing of NDA for Levosert™ IUD 4:30 p.m. July 21, 2014 - PR Newswire - PRF
Drug Application Submission, Merger Agreement, Launch of Newly Approved Drug, and Acquisition - Analyst Notes on Actavis, Salix, Mylan, Zoetis and Hospira 5:10 a.m. July 14, 2014 - PR Newswire - PRF
Actavis Confirms Generic Diclegis® Patent Challenge 4:25 p.m. July 11, 2014 - PR Newswire - PRF

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CJ BIO's Bold Steps for Sustainable Animal Nutrition

Updated Category News Views 54

Breaking New Ground in Animal Nutrition Picture this: industry big wigs and farmers alike, all rubbing elbows at EuroTier 2026, the grand meeting ground for animal nutrition's future. This is where CJ BIO is flexing its muscles, not by just tossing ingredients into the mix, but by revolutionizing them under the banner "Feed Intelligence for Sustainable Performance." Now,...

Continue Reading
Karma Automotive Debuts High-Stakes Eximius Program

Updated Category News Views 250

Breaking Ground with Bespoke Engineering Fancy seeing a car more unique than a snowflake, eh? Well, Karma Automotive is upending the luxury vehicle market with the launch of the Eximius program. Catering to the whims of the elite who aren’t just satisfied with a plethora of options, this is a game for those who crave a motorized extension of their ego and address book....

Continue Reading
SKYWORTH Solar's Solavita: Energizing Global Microgrids

Updated Category News Views 188

Aiming for Global Reach with Solavita Usually, when a company flings a new brand into the arena, you're looking at a whole bunch of promises and probably a fat folder of paperwork you don't want to read. But when SKYWORTH Solar dishes out Solavita as its new ace in the smart microgrid game, you reckon there's a bit of serious starch in the collar. Harnessing Worldwide...

Continue Reading
Langford Chosen for Navy Mutual's 2026 Bolles Award

Updated Category News Views 372

Awarding a Military Financial Educator There's something profoundly rewarding when hard work and dedication get their due recognition. That's precisely what's happened for Lacey Langford, who’s just been awarded the Lieutenant Timothy Dix Bolles Excellency in Education Award by the Navy Mutual Aid Association, or simply Navy Mutual. This isn’t just some...

Continue Reading
Wulcea Pioneers Safety in Smart Heated Apparel

Updated Category News Views 164

Tech Behind the Warmth and Safety You ever turn on a heated jacket and wonder if it'll keep you safe as much as warm? That's the scene with Wulcea, a brand diving headfirst into the smart heated clothing market. People are waking up to what’s inside these technological coats, not just how they feel on a frosty walk. It’s the kind of scenario where safety meets...

Continue Reading
DKS Lawsuit Deadline: Investors Must Act by Nov 3, 2026

Updated Category News Views 149

Clock's Ticking for DICK'S Investors If you've got money tied up in DICK'S Sporting Goods—bought between September 8, 2025, and August 24, 2026—listen up. There's a class action lawsuit aiming to recover some of what might've slipped through your fingers. Come November 3, 2026, the door slams shut on your chance to get involved. What's the Beef? Apparently, DICK'S had...

Continue Reading
Race for Life Rescue Logs 200 Flights for Shelter Pets

Updated Category News Views 278

Airborne Lifelines for Vulnerable Animals Ever picture an airplane filled with hope? Well, Race for Life Rescue isn't just carting metal through the sky; they're lifting spirits, one furry passenger at a time. Picture this: a nonprofit turning a clunky Beechcraft into a flying ark, whisking away 112 at-risk pets from Louisiana to fresh starts in the Northeast. And guess...

Continue Reading
Bass Angler Matt Robertson Reels in Record $1.25M Prize

Updated Category News Views 141

A New Era for Bass Fishing Payouts Who would have thought we'd see the day when bass fishing turned out to be as lucrative as a Wall Street handshake? But here we are, with Matt Robertson hauling in a whopping $1.25 million prize at World Bass Enterprises' first "The Champions" Tournament. We're not talking chump change here—this is the real deal in a sport often...

Continue Reading
HanAll F&B Pioneers New Path for Domestic Rice Noodles

Updated Category News Views 316

New Spin on an Old Favorite: Rice Noodles Forget about the same old wheat noodles clogging up the pantry. HanAll F&B is revamping the noodle game with a homegrown twist, setting sights on a future where Korean rice isn't just for steaming, soup, or sushi. This outfit from Taebaek, Gangwon, has got its hands deep in the rice flour, finessing a patent that aims to make...

Continue Reading
UBCF & GGP Join Forces for Nationwide Pink Bag Drive

Updated Category News Views 223

Caring Through Community: Pink Bag Events Unroll What do you get when compassion meets action? That's the story with the United Breast Cancer Foundation (UBCF) and GGP's Pink Bag Event. Here in 2026, these folks are doing something so damn important, you'd wonder why more don’t follow suit. For the fifth straight year, they're rolling out a campaign that bridges the gap...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights on QuantumScape’s Upcoming Earnings Report

Updated Category News Views 62

Insights into QuantumScape’s Earnings Announcement QuantumScape (NYSE: QS) is gearing up to share its quarterly earnings report soon. As the anticipated date comes, it's essential for investors to understand the key aspects surrounding the announcement. Analysts have set expectations for QuantumScape to report an earnings per share (EPS) of $-0.21. This figure is based...

Continue Reading
Investigation Launched Over Playa Hotels & Its Shareholder Deal

Updated Category News Views 177

Playa Hotels & Resorts N.V. Faces Investigation Ademi & Fruchter LLP has initiated an investigation into Playa Hotels & Resorts N.V. (NASDAQ: PLYA), focusing on whether the company is delivering a fair price to its shareholders amidst a recent merger agreement with Hyatt. Shareholders of Playa are poised to receive $13.50 per share as part of this transaction, translating...

Continue Reading
Optimistic Market Trends as Investors Embrace Economic Insights

Updated Category News Views 220

Positive Outlook for U.S. Stocks Amid Increasing Investor Confidence The environment for U.S. stocks appears encouraging as a rejuvenated investor sentiment sets the stage for a potentially positive market performance. The Dow Jones index recently made headlines by achieving a new record high, showcasing the optimism that has permeated the market. Key Developments...

Continue Reading
Ark Invest's Strategic Move: Robinhood Shares Sold Off

Updated Category News Views 315

Ark Invest Engages in Notable Trades Amid Market Shifts Cathie Wood's Ark Invest is generating headlines with a significant sell-off of shares from Robinhood Markets Inc (NASDAQ: HOOD), amounting to a remarkable $5.8 million. This is part of Ark's strategy to actively manage their ETF portfolios, and it highlights the dynamic nature of investment in the tech-driven...

Continue Reading
Solana Price Surge: A Look at the Latest Trends and Stats

Updated Category News Views 96

Solana's Recent Price Movement Solana's cryptocurrency, represented by the ticker SOL/USD, has made headlines with a remarkable increase of 3.24% in just the past 24 hours, bringing the current price to $139.63. This uptick comes after a challenging week, during which Solana experienced a significant decline of 12.0%, with its price dropping from $160.19 to its current...

Continue Reading